Table 1.
Demographic characteristics and tumor characteristics of the three compared groups
| Hand-sewn (n = 64; 27.8%) | Circular-stapler (n = 71; 30.9%) | Liner-stapler (n = 95; 41.3%) | P | |
|---|---|---|---|---|
| Characteristics | ||||
| M/F (%) | 54/10 (84.4/15.6) |
68/3 (95.8/4.2) |
83/12 (87.4/12.6) |
0.081 |
| Age | 66.4 ± 10.6 | 63.6 ± 9.6 | 65.6 ± 9.1 | 0.210 |
| BMI | 25.5 ± 4.1 | 27.1 ± 3.9 | 26.7 ± 3.9 | 0.065 |
|
ASA 1 (%) 2 (%) 3 (%) 4 (%) |
15 (23.4%) 16 (25%) 14 (21.9%) 19 (29.7%) |
13 (18.3%) 24 (33.8%) 18 (25.4%) 16 (22.5%) |
22 (23.2%) 30 (31.6%) 25 (26.3%) 18 (18.9%) |
0.714 |
| Hypertension (%) | 41 (64.1%) | 33 (46.5%) | 46 (48.4%) | 0.079 |
| Diabetes (%) | 11 (17.2%) | 12 (16.9%) | 16 (16.8%) | 0.998 |
| Congestive heart failure (%) | 7 (10.9%) | 9 (12.7%) | 8 (8.4%) | 0.667 |
| COPD (%) | 8 (12.5%) | 10 (14.1%) | 18 (18.9%) | 0.508 |
| Smoking (%) | 25 (39.1%) | 18 (25.3%) | 21 (22.1%) | 0.227 |
|
T Tis (%) T0 (%) T1 (%) T2 (%) T3 (%) T4 (%) |
0 6 (9.4%) 5 (7.8%) 16 (25%) 37 (57.8%) 0 |
1 (1.4%) 16 (22.5%) 6 (8.5%) 17 (24%) 30 (42.2%) 1 (1.4%) |
2 (2.1%) 13 (13.7%) 12 (12.6%) 19 (20%) 46 (48.4%) 3 (3.2%) |
0.254 |
|
N N0 (%) N1 (%) N2 (%) N3 (%) |
29 (45.3%) 14 (21.9%) 8 (12.5%) 13 (20.3%) |
40 (56.3%) 15 (21.1%) 12 (16.9%) 4 (5.6%) |
53 (55.8%) 24 (25.3%) 8 (8.4%) 10 (10.5) |
0.119 |
|
M Mx (%) M0 (%) M1 (%) |
2 (3.1%) 62 (96.9%) 0 |
0 70 (98.6%) 1 (1.4%) |
4 (4.2%) 91 (95.8%) 0 |
0.275 |
| Neoadjuvant therapy (%) | 28 (43.7%) | 38 (53.5%) | 42 (44.2) | 0.411 |
Categorical variables are expressed as numbers and (percentages), while continuous variables are expressed as mean ± SD
M male, F female, BMI body mass index, ASA score American Society of Anesthesiology score, COPD chronic obstructive pulmonary disease